SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005598
Filing Date
2017-08-01
Accepted
2017-08-01 16:16:07
Documents
50
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20170630x10q.htm 10-Q 927287
2 EX-31.1 zyne-20170630ex311ea8de7.htm EX-31.1 13588
3 EX-31.2 zyne-20170630ex312c3fd20.htm EX-31.2 13382
4 EX-32.1 zyne-20170630ex3211c29b9.htm EX-32.1 6171
5 EX-32.2 zyne-20170630ex322cf7843.htm EX-32.2 6187
6 GRAPHIC zyne20170630x10q001.jpg GRAPHIC 87315
  Complete submission text file 0001558370-17-005598.txt   3902533

Data Files

Seq Description Document Type Size
7 EX-101.INS zyne-20170630.xml EX-101.INS 803119
8 EX-101.SCH zyne-20170630.xsd EX-101.SCH 25879
9 EX-101.CAL zyne-20170630_cal.xml EX-101.CAL 30696
10 EX-101.DEF zyne-20170630_def.xml EX-101.DEF 107475
11 EX-101.LAB zyne-20170630_lab.xml EX-101.LAB 243774
12 EX-101.PRE zyne-20170630_pre.xml EX-101.PRE 206633
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 17996919
SIC: 2834 Pharmaceutical Preparations